CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH5), PE, eBioscience™, Invitrogen™ 50 μg; PE CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH5), PE, eBioscience™, Invitrogen™ | Fisher Scientific
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis - ScienceDirect
The CTLA‐4 immune checkpoint protein regulates PD‐L1:PD‐1 interaction via transendocytosis of its ligand CD80 | The EMBO Journal
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways - ScienceDirect
Cancers | Free Full-Text | PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression
Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma | Anticancer Research
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Frontiers | From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
Survival analysis with regard to PD‑L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors
Animals | Free Full-Text | The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology
![Recombinant Anti-PD-L1 antibody [CAL10] - Rat IgG2a (Chimeric) KO Tested (ab279294)](https://www.abcam.com/ps/products/279/ab279294/Images/ab279294-477254-anti-pd-l1-antibody-cal10-chimeric-western-blot-wildtype-a549-treated-ifn-100-ngml-for-48-hours-cd274-knockout-a549-t-rat.jpg "Recombinant Anti-PD-L1 antibody [CAL10] - Rat IgG2a (Chimeric) KO Tested (ab279294)")
Recombinant Anti-PD-L1 antibody [CAL10] - Rat IgG2a (Chimeric) KO Tested (ab279294)
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
PD-1-mediated immune regulation. Under low expression levels of PD-L1,... | Download Scientific Diagram
PD-L1 Anticorps (ABIN7266181)
An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity | Cellular & Molecular Biology Letters | Full Text
Should we consider blocking the inhibitory immune checkpoint molecules for treating T cell exhaustion in sepsis? | Intensive Care Medicine
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain | Nature Communications
PD-L1 (Fc-Fusion) – AB Biosciences
Biomedicines | Free Full-Text | PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas
Interaction between PD-1/PD-L1 and T cell immune response. T cells are... | Download Scientific Diagram
CD274 (PD-L1, B7-H1) Monoclonal Antibody (MIH1), Biotin, eBioscience™, Invitrogen™: Primary Antibodies - Alphabetical Anticorps primaires | Fisher Scientific
PD-1-PD-L1/2 pathway mechanism in cancer and under physiologic conditions. | Download Scientific Diagram
Animals | Free Full-Text | The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology
